tiprankstipranks
Biotest AG (DE:BIO)
XETRA:BIO
Holding DE:BIO?
Track your performance easily

Biotest (BIO) Cash flow

3 Followers

Biotest Cash Flow

DE:BIO's free cash flow for Q4 2022 was €-53.00M. For the 2022 fiscal year, DE:BIO's free cash flow was decreased by €-85.50M and operating cash flow was €-23.70M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
€ -40.50M€ -40.50M€ 33.90M€ -16.70M€ -33.60M€ -50.00M
Investing Cash Flow
€ -37.00M€ -37.00M€ -23.40M€ -14.60M€ -8.00M€ 200.80M
Financing Cash Flow
€ 89.60M€ 89.60M€ 22.60M€ 42.00M€ 40.50M€ -111.20M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
€ 370.20M€ 116.60M€ 104.40M€ 71.30M€ 60.80M€ 61.90M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
-€ 100.00M€ 25.10M€ 50.00M€ 46.40M€ 500.00M
Repayment Of Debt
-€ 0.00€ 0.00€ -2.50M€ -4.00M€ -595.20M
Free Cash Flow
€ -69.80M€ -69.80M€ 15.70M€ -43.70M€ -67.70M€ -104.60M
Domestic Sales
------
Foreign Sales
------
Currency in EUR

Biotest Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis